DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Jacquemin M, Toelen J, Schoeters J. , et al.
The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders.
J Thromb Haemost 2015;
13 (11) 2087-2092
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.